药品注册申请号:209285
申请类型:ANDA (仿制药申请)
申请人:CHARTWELL RX
申请人全名:CHARTWELL RX SCIENCES LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CLONIDINE HYDROCHLORIDE CLONIDINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 0.1MG No No AB1 2017/10/23 2017/10/23 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2020/05/21 SUPPL-3(补充) Approval Labeling STANDARD
2020/05/21 SUPPL-1(补充) Approval Labeling STANDARD
2017/10/23 ORIG-1(原始申请) Approval STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:CLONIDINE HYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:0.1MG 治疗等效代码:AB1
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022331 003 NDA KAPVAY CLONIDINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 0.1MG Discontinued Yes No AB1 2010/09/28 CONCORDIA PHARMS INC
202984 001 ANDA CLONIDINE HYDROCHLORIDE CLONIDINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 0.1MG Discontinued No No AB1 2013/09/30 ENDO OPERATIONS
203320 001 ANDA CLONIDINE HYDROCHLORIDE CLONIDINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 0.1MG Prescription No No AB1 2015/05/15 ACTAVIS ELIZABETH
209285 001 ANDA CLONIDINE HYDROCHLORIDE CLONIDINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 0.1MG Prescription No No AB1 2017/10/23 CHARTWELL RX
209686 001 ANDA CLONIDINE HYDROCHLORIDE CLONIDINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 0.1MG Prescription No Yes AB1 2017/11/20 AJANTA PHARMA LTD
209757 001 ANDA CLONIDINE HYDROCHLORIDE CLONIDINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 0.1MG Prescription No No AB1 2017/11/20 XIAMEN LP PHARM CO
210052 001 ANDA CLONIDINE HYDROCHLORIDE CLONIDINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 0.1MG Discontinued No No AB1 2017/11/20 AMNEAL PHARMS NY
210338 001 ANDA CLONIDINE HYDROCHLORIDE CLONIDINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 0.1MG Prescription No No AB1 2018/01/29 JUBILANT GENERICS
209675 001 ANDA CLONIDINE HYDROCHLORIDE CLONIDINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 0.1MG Prescription No No AB1 2019/03/05 NOVAST LABS
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database